Valuing IPOs

Valuing an IPO requires answering two related but different questions: what the underlying business is worth, and what price should be used when its shares are first sold to the public. Those numbers can be close, but they are not the same thing. The offering price is shaped by business analysis, market conditions, negotiations between the company and its underwriters, and indications of demand from prospective investors. The SEC describes it as a negotiated estimate of value and warns that the stock’s trading price shortly after the offering can be materially higher or lower.^[1]

That distinction matters because IPOs arrive without the long public trading history investors have for established stocks. A private company may have only a few years of meaningful financial data, its future margins may still be developing, and its capital structure can change substantially when preferred shares, employee equity awards and new IPO shares are converted or issued. A sensible valuation therefore starts with the economics of the business, then adjusts for the financing and share structure that will exist after the offering.

The process of IPOs also creates a second layer of uncertainty. Underwriters need to place a large block of stock with investors at a price the issuer can accept, while public-market buyers later decide what they are willing to pay in continuous trading. An investor who treats the offer price, the first trade and an estimate of intrinsic value as interchangeable can end up confusing three different prices produced by three different processes.

What is actually being valued in an IPO

Most IPO valuation work moves through three levels: the value of the operating business, the value attributable to common equity, and the value per diluted share. The first level is often expressed as enterprise value, which is intended to capture the value of the core business independent of how it is financed. To move from enterprise value to equity value, analysts normally account for cash, debt and other claims that sit ahead of common shareholders. The final step divides the resulting common-equity value by an appropriate diluted share count.

That sounds mechanical, but IPOs complicate each step. A primary offering creates new shares and brings cash into the company, while a secondary offering sells shares owned by existing holders and sends the proceeds to those sellers instead. Many transactions contain both. If the company raises fresh cash, the post-offering balance sheet may have materially more cash and a different debt position than the historical balance sheet shown in earlier periods. Valuation should be consistent about whether it is using a pre-offering or post-offering capital structure so that the IPO proceeds are not ignored or counted twice.

The denominator can be just as important as the numerator. A headline calculation based only on the shares sold in the IPO or the basic shares outstanding can understate the economic share count if preferred stock converts into common stock, options are in the money, restricted stock units are expected to vest, or other equity awards are outstanding. Investors should distinguish the number of shares offered from total shares outstanding after the IPO and from a fully diluted share count used for valuation. A company with a low-looking share price is not necessarily cheap if there are many more shares and equity claims behind that price.

Why IPO valuation is unusually difficult

Established public companies give investors a long trail of quarterly reports, margins across business cycles, market reactions, capital allocation decisions and trading data. An IPO candidate often provides much less history, and the period that is available may reflect an unusually rapid growth phase. The task is not merely to extend recent numbers forward. The analyst has to decide how quickly growth will slow, whether current unit economics can support attractive margins, how much reinvestment the business will require and what risks could prevent the projected business from emerging.

Young and high-growth companies are especially difficult to value because conventional metrics can fail at the same time. A company with losses has no meaningful price-to-earnings ratio, an early-stage business may have a small accounting book value relative to the economic assets it is building, and even revenue multiples can be misleading when companies with similar sales have very different margins, growth rates and capital needs. Research from NYU Stern on valuing young and growth companies emphasizes these problems with both discounted cash flow and relative valuation, including the difficulty of finding genuinely comparable public companies.^[2]

Private-company financing creates another complication. Before an IPO, different investors may own securities with preferences, conversion features, protective provisions or other rights that are not identical to ordinary public common stock. The IPO can simplify some of those claims when preferred shares convert, but an investor still needs to understand what the post-offering common shareholder actually owns. The prospectus sections covering capitalization, dilution, principal shareholders and the description of capital stock are often more useful for this purpose than a headline pre-IPO valuation reported elsewhere.

The absence of a public price history does not make valuation impossible, but it does make false precision particularly dangerous. A model that produces $27.43 per share is not necessarily more informative than one that produces a reasonable range of $23 to $30. The range makes the assumptions visible. If a small change in long-term margin, revenue growth or the valuation multiple moves the result by 30 percent, that sensitivity is part of the investment case rather than an inconvenience to be hidden.

How comparable-company valuation is used

Comparable-company analysis is central to IPO pricing because public companies provide observable market values for businesses that investors already know. The NYSE notes that companies pursuing an IPO will be compared by analysts and investors with existing public companies, which makes peer positioning an important part of preparing to go public.^[3] The usefulness of that comparison depends much more on the quality of the peer group than on the number of companies placed in a spreadsheet.

Industry labels alone are not enough. Two software companies can have very different revenue models, customer acquisition costs, retention rates, gross margins and capital requirements. Two retailers with similar sales can deserve very different valuations if one operates mature stores with low growth and the other has a rapidly expanding, high-return footprint. Good peer selection focuses on the economic drivers that determine cash generation rather than on a superficial category match.

The valuation multiple should also match the stage of the business. Profitable, mature companies can often be compared using earnings or EBITDA-based multiples, provided accounting and capital structures are reasonably comparable. A loss-making growth company may require an enterprise-value-to-revenue measure, but revenue is not a substitute for profitability. The multiple should reflect expected growth, gross margin, the path to operating profitability, reinvestment needs and business risk. A company growing 50 percent with strong retention and improving margins should not automatically receive the same revenue multiple as one growing 20 percent with weak economics merely because both report the same type of revenue.

Enterprise-value multiples and equity-value multiples should not be mixed casually. Enterprise value is compared with operating measures that belong to all capital providers, such as revenue or EBITDA, while equity value is compared with measures attributable to common shareholders, such as net income. After a reasonable enterprise value is estimated, cash, debt and other claims are used to reach equity value. This bridge is where IPO proceeds, debt repayment and other transaction effects have to be handled consistently.

Peer multiples are ultimately market prices expressed in another form, so they inherit the market’s optimism or pessimism. When an entire sector is expensive, a relative valuation can make an IPO look reasonable even if the sector itself is richly priced. When sentiment is depressed, the same method can produce a much lower result without any deterioration in the company’s operations. That is one reason fundamental data and a separate assessment of future cash generation are useful checks rather than optional extras.

Using discounted cash flow as a second lens

A discounted cash flow valuation approaches the problem from the business inward rather than from the market outward. The analyst forecasts the cash the company could generate for investors, adjusts those future cash flows for time and risk, and estimates a terminal value for the period after explicit forecasts end. For an IPO candidate, the difficult work is not the discounting formula. It is building a coherent picture of how the business might move from today’s revenue, margins and investment needs toward a more mature state.

Revenue growth should connect to an addressable market, competitive position and the investment required to win customers. Margin assumptions should reflect the cost structure the company could reasonably reach rather than simply adopting the margin of the most successful public peer. Reinvestment also matters because growth usually consumes capital somewhere, whether through physical assets, working capital, product development, sales capacity, acquisitions or other spending. A forecast that assumes rapid growth and rapidly rising margins without enough reinvestment deserves skepticism.

Terminal value can dominate a growth-company DCF because much of the expected cash generation lies far in the future. Small changes in the assumed mature growth rate, long-run margin or discount rate can therefore have a large effect on present value. Rather than hiding that sensitivity, investors can use scenarios. A conservative case might assume slower growth and a lower mature margin, a central case can reflect the most defensible operating path, and an optimistic case can show what must go right for a premium valuation to be justified.

DCF and comparable-company analysis are not competing religions. If the two methods produce very different answers, the gap is useful information. A DCF far below the peer-based value may mean the market is pricing unusually strong growth, unusually durable margins or a lower risk premium than the model assumes. A DCF far above peer values may indicate that the model is too optimistic or that the market is assigning a temporary discount to the sector. The investor’s task is to understand the assumptions responsible for the difference.

How market conditions and bookbuilding affect the offer price

The valuation work gives the issuer and its underwriters a starting range, but the final offer price also has to clear a real market. During marketing, Investment banks gather indications of interest from institutional investors. The resulting order book shows how many shares investors say they want and at what prices. Strong demand can support pricing near the top of an indicated range or above it, while weak demand can force a lower price, a smaller deal or a delay.

Broader conditions influence that demand. Equity-market volatility, the performance of recent IPOs, sector sentiment and investors’ willingness to own growth or riskier assets can all change during the offering process. The timing of the release of an IPO therefore matters even when the company’s own financial outlook has not changed. An issuer that could command a premium valuation in an enthusiastic market may face a much lower multiple when investors become more selective.

The issuer and the underwriters do not have perfectly identical incentives. A higher offer price raises more money per new share for the company, but an aggressive price can reduce demand and make the deal harder to place. Institutional buyers want enough expected return to compensate them for the uncertainty of a new issue. Underwriters want a successful distribution and a workable aftermarket. The final number is a negotiated transaction price that incorporates these competing objectives, not a scientific declaration of fair value.

This helps explain why a first-day increase is not, by itself, proof that every analyst involved valued the company incorrectly. An offering can be priced with some room for investors, demand can strengthen late in the process, and the tradable supply can be limited. Once the shares begin trading in the secondary market, the price is set by buyers and sellers who were not bound by the offering negotiations. A large opening move tells investors something about immediate demand, but it does not settle what the business is worth over a multi-year holding period.

Primary shares, secondary shares and dilution

Valuation becomes clearer when the offering is separated into primary and secondary shares. Primary shares are newly issued by the company, so the company receives the net proceeds and the existing owners are diluted by the additional shares. Secondary shares are sold by existing shareholders, so the company does not receive those proceeds and the sale does not itself create new shares. The mix affects both the balance sheet and the economic purpose of the transaction.

Fresh capital can increase equity value if it remains as cash or is used to reduce debt, but the new shares issued to obtain that cash also increase the number of claims on the equity. Investors should therefore avoid the shortcut of adding gross IPO proceeds to a pre-IPO equity valuation without also reflecting new shares and transaction costs. A clean approach values the operating business, builds a post-offering estimate of net cash or net debt, and then divides post-offering equity value by the relevant diluted share count.

Suppose a hypothetical company is valued at an enterprise value of $3.0 billion. After the IPO it is expected to have $500 million of cash and $100 million of debt, leaving $400 million of net cash. That would imply about $3.4 billion of common equity value before considering any other claims. If the fully diluted post-offering share count is 140 million, the implied value would be roughly $24.30 per share. If someone instead divided by 110 million basic shares, the result would exceed $30 and would make the same company look much more valuable simply because the denominator was incomplete.

The example also shows why the use of proceeds matters. Cash that will immediately repay debt changes the balance sheet differently from cash that will fund years of expansion, and shares sold solely by existing holders do not add cash to the company at all. Investors evaluating companies who issue them should read the prospectus to see how much of the transaction is raising capital for the business and how much is providing liquidity to current owners.

What to read in the prospectus before accepting the valuation

The prospectus is the best starting point because it brings the transaction terms and the company’s disclosures into one document. The financial statements show reported revenue, margins, cash flows and balance-sheet items. Management’s discussion and analysis explains important drivers and changes in those numbers. The business section gives context on customers, suppliers, competition and the operating model. None of these sections supplies a ready-made fair value, but together they provide the inputs needed to build one.

For a growth company, revenue quality often matters as much as revenue growth. Investors should look for customer concentration, recurring versus transactional revenue, churn or retention information when disclosed, dependence on a small number of products, geographic concentration and unusual related-party relationships. A company that is growing quickly because one customer expanded spending has a different risk profile from one growing at the same rate across a broad customer base.

Profitability deserves the same treatment. Reported net losses do not automatically make a company unattractive, and reported adjusted profits do not automatically make it economically profitable. Stock-based compensation, capitalization of certain costs, acquisition-related adjustments and large non-GAAP exclusions can materially change the picture. The relevant question is what operating margins and free cash flow could look like after the company reaches a more mature growth rate, and how much additional capital must be invested to get there.

The capitalization and dilution sections help translate business value into per-share value. They show how preferred shares, debt and new equity interact around the offering. The principal and selling shareholders section identifies major owners and how their holdings change. The underwriting section explains the offering mechanics, while the use-of-proceeds section describes what the company expects to do with the capital it raises. Reading these together is far more informative than looking only at the proposed price range on the cover.

Governance can also affect what a share is worth to a public investor. Dual-class structures can leave founders or insiders with voting control that is much greater than their economic ownership. Related-party arrangements, concentrated voting rights and unusually large equity compensation programs can alter the balance between growth and shareholder dilution. These features do not produce a mechanical valuation discount in every case, but they belong in the risk assessment because public shareholders are buying a specific bundle of economic and governance rights.

Common valuation errors with IPOs

One of the easiest mistakes is to confuse a low nominal share price with a low valuation. A $10 stock can be more expensive than a $100 stock if the first company has enough shares outstanding. Market capitalization and enterprise value, not the dollar price of one share, are the useful starting points. The same logic applies when comparing an IPO with a private funding round whose share classes or preferred terms were different.

Another error is choosing peers because they are famous or operate in the same broad sector. The multiple of a dominant, high-margin company may be a poor benchmark for a smaller issuer with weaker economics. Conversely, using a slow-growth incumbent as the only reference point can understate the value of a business that is taking share quickly and has credible evidence that its margins will improve. Comparable analysis works best when the analyst can explain why the selected companies resemble the IPO candidate on the drivers that matter.

Rapid revenue growth can also distract from the conversion of revenue into cash. Some business models need heavy marketing spending to maintain growth, some require large working-capital investment, and others face infrastructure or regulatory costs that rise with scale. A premium revenue multiple is difficult to justify if the company’s growth does not eventually produce attractive cash returns on the capital invested to achieve it.

The first day of trading creates another trap. A stock that jumps 40 percent has not suddenly produced 40 percent more factories, customers or cash flow between the pricing meeting and the opening trade. The move reflects the price at which marginal buyers and sellers meet in a market with a limited initial float. It can be evidence that demand was stronger than expected, but using the opening pop as proof of long-term value reverses the logic of valuation by allowing the price itself to become the reason the price is justified.

Finally, investors can underestimate dilution and future supply. Employee equity awards, option exercises and later stock issuance can increase the share count, while lock-up expirations can make more existing shares available for sale. None of these facts means an IPO must decline, but they affect per-share economics and the relationship between the small initial public float and the company’s total equity base. A valuation that stops at the number of shares offered is incomplete.

How an investor can use valuation without pretending to know the exact price

A useful IPO valuation is a range tied to explicit assumptions. Start with the operating business and estimate what revenue growth, margins and reinvestment would have to look like for the company to justify different enterprise values. Use comparable companies to see what the market is paying for similar economics, then use a cash-flow framework to test whether those prices imply plausible long-term outcomes. Reconcile enterprise value to post-offering equity value and use a diluted share count that reflects the securities disclosed in the prospectus.

The next step is to compare that range with the price actually available. An investor allocated shares at the offering price faces one decision, while an investor considering the stock after it opens 30 percent higher faces another. The business has barely changed, but the expected return from the purchase price has. Valuation remains useful precisely because it prevents enthusiasm about the company from becoming indifference to the price paid.

Uncertainty should be handled through scenarios and position sizing rather than through a claim that the model can identify a perfect number. If a reasonable conservative case implies substantial downside from the current price and the optimistic case is needed merely to justify today’s valuation, the risk-reward balance is different from an IPO priced near the lower end of a defensible range. Investors can still disagree because they will use different forecasts and required returns, but the disagreement becomes about assumptions that can be examined.

The most important separation is between a good company, a good IPO transaction and a good investment at the price available to you. A strong business can be overpriced, a mediocre business can occasionally be offered cheaply, and a well-priced offering can become unattractive after a large first-day rise. Valuing IPOs is therefore less about predicting the opening trade than about establishing what future business performance is already embedded in the price and deciding whether that performance is credible enough to justify the risk.